Skip to content
Delayed ~15 min
← S&P 500

GILD Gilead Sciences

Health Care · S&P 500 · Nasdaq 100

Next earnings: not announced yet

What 34 analyst firms say about Gilead Sciences: their latest ratings, price targets and how far the stock is from them. How it works

166.89 USD−0.68 (−0.41%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+0.4%to the avg target 167.52 USD+0.63 USD
Buy 26 · Hold 7 · Sell 0

33 rated views · 35 analyst/firm records · 34 firms

Latest report30 Oct 2026avg report date 20 Aug
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • S&P 500 · Top Picks · 6MBelow the Radar threshold of 8045
  • S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8069
Other indices (1)
  • Nasdaq 100 · Top Picks · 6MBelow the Radar threshold of 8034
  • Nasdaq 100 · Safest consensus · 6MBelow the Radar threshold of 8064

Recent analyst activity · last 90 days

Our tracked history has 27 reports on GILD from 21 analyst firms in the last 90 days (34 firms in the past year).

Comparing each firm's latest target with its previous one: 12 raised their price target, 3 left it unchanged and 3 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: BMO Capital raised its target from $174.00 (set 13 Jul 2026) to $184.00 on 30 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
ArgusJasper HellwegBuy17 Aug 2026165.00 USD
BairdBrian P SkorneyHold1 Sep 2026145.00 USD
Bank of America SecuritiesTim AndersonBuy20 Oct 2026172.00 USD
BarclaysEmily FieldHold29 Jul 2026145.00 USD
BernsteinCourtney BreenBuy7 Sep 2026160.00 USD
BMO Capital MarketsEvan David SeigermanBuy30 Oct 2026184.00 USD
Cantor FitzgeraldCarter GouldBuy30 Oct 2026175.00 USD
CitigroupGeoff MeachamBuy30 Oct 2026188.00 USD
DaiwaNarumi NakagiriBuy15 Sep 2026150.00 USD
DBSNico ChenBuy1 Jul 2026140.00 USD
Deutsche BankUnnamed analystBuy11 Feb 2026155.00 USD
DZ BankElmar KrausBuy7 Aug 2026167.00 USD
Erste GroupHans EngelHold25 Jun 2026—
Evercore ISIUmer RaffatBuy1 Jul 2026—
Goldman SachsSalveen RichterHold5 Aug 2026142.00 USD
HSBCMorten HerholdtBuy10 Sep 2026175.00 USD
JefferiesAkash TewariBuy23 Oct 2026185.00 USD
JPMorganChris SchottBuy30 Oct 2026190.00 USD
Leerink PartnersDaina GrayboschHold21 Jul 2026127.00 USD
Maxim GroupMichael OkunewitchBuy20 May 2026165.00 USD
MizuhoSalim SyedBuy19 Feb 2026170.00 USD
Morgan StanleyMatthew HarrisonBuy30 Oct 2026183.00 USD
NeedhamJoseph StringerConflictConflicting reports · excluded30 Oct 2026Conflicting reports · excluded
OppenheimerUnnamed analystBuy11 Feb 2026165.00 USD
RBC Capital MarketsBrian AbrahamsHold30 Oct 2026131.00 USD
RedburnSimon BakerBuy6 Aug 2026168.00 USD
ScotiabankLouis ChenBuy30 Oct 2026200.00 USD
TD CowenTyler Van BurenBuy30 Oct 2026175.00 USD
TruistGregory RenzaBuy30 Oct 2026181.00 USD
UBSDavid DaiBuy5 Aug 2026Conflicting reports · excluded
UBSMichael YeeBuy30 Oct 2026195.00 USD
Weiss RatingsUnnamed analyst—14 Sep 2026—
Wells FargoMohit BansalBuy30 Oct 2026190.00 USD
Wolfe ResearchAlexandria HammondBuy12 Feb 2026170.00 USD
Data feed RESEARCHResearch TeamHold29 Sep 2026Conflicting reports · excluded

Partial coverage · checked 6 Nov (6 Nov 2026, 03:55 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.